Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 6 51-6, 2005, Pages

  Pillutla, Priya ^a,c   Hwang, Yuying C ^a   Augustus, Ayanna ^a   Yokoyama, Masayoshi ^a   Yagyu, Hiroaki ^a   Johnston, Thomas P ^b   Kaneko, Michiyo ^a   Ramasamy, Ravichandran ^a   Goldberg, Ira J ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Fatty acid metabolism; Lipoprotein lipase; Lipotoxicity; Triglyceride

Indexed keywords

ALBUMIN; CARBON 14; CHOLESTEROL ESTER; ENZYME INHIBITOR; HEPARIN; INTRALIPID; LIPOPROTEIN LIPASE; PALMITIC ACID; POLOXAMER; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; ENERGY METABOLISM; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GENE OVEREXPRESSION; HEART DISEASE; HEART MUSCLE CELL; HEART PERFUSION; ISOLATED HEART; LIPID METABOLISM; LIPOTOXIC CARDIOMYOPATHY; LIPOTOXICITY; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXICITY;

AGE FACTORS; ANIMALS; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FAT EMULSIONS, INTRAVENOUS; LIPOPROTEIN LIPASE; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; MYOCYTES, CARDIAC; PALMITATES; PERFUSION;

EID: 19444382326     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00273.2004     Document Type: Article

References (20)

1. Abumrad N, Harmon C, and Ibrahimi A. Membrane transport of long-chain fatty acids: evidence for a facilitated process. J Lipid Res 39: 2309-2318, 1998.
2. Augustus AS, Kako Y, Yagyu H, and Goldberg U. Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA. Am J Physiol Endocrinol Metab 284: E331-E339, 2003.
3. Barger PM and Kelly DP. Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. Am J Med Sci 318: 36-42, 1999.
4. Bergmann SR, Herrero P, Sciacca R, Hartman JJ, Rubin PJ, Hickey KT, Epstein S, and Kelly DP. Characterization of altered myocardial fatty acid metabolism in patients with inherited cardiomyopathy. J Inherit Metab Dis 24: 657-674, 2002.
5. Chiu HC, Kovacs A, Ford DA, Hsu FF, Garcia R, Herrero P, Saffitz JE, and Schaffer JE. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 107: 813-822, 2003.
6. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, and Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275: 32523-32529, 2000.
7. Fielding CJ. Metabolism of cholesterol-rich chylomicroms. Mechanism of binding and uptake of cholesteryl esters by the vascular bed of the perfused rat heart. J Clin Invest 62: 141-151, 1978.
8. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, and Kelly DP. The cardiac phenotype induced by PPAR(alpha)overexpression mimics that caused by diabetes mellitus. J Clin Invest 109: 121-130, 2002.
9. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37: 693-707, 1996.
10. Hultin M, Carneheim C, Rosenqvist K, and Olivecrona T. Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons. J Lipid Res 36: 2174-2184, 1995.
11. Hwang YC, Sato S, Tsai JY, Bakr S, Yan SD, Oates PJ, and Ramasamy R. Aldose reductase activation is a key component of myocardial response to ischemia. FASEB J 16: 243-245, 2002.
12. Johnston TP and Palmer WK. Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat. Biochem Pharmacol 46: 1037-1042, 1993.
13. Kasper EK, Hruban RH, and Baughman KL. Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure. Am J Cardiol 70: 921-924, 1992.
14. Mardy K, Belke DD, and Severson DL. Chylomicron metabolism by the isolated perfused mouse heart. Am J Physiol Endocrinol Metab 281: E357-E364, 2001.
15. Ramasamy R, Hwang YC, Bakr S, and Bergmann SR. Protection of ischemic hearts perfused with an anion exchange inhibitor, DIDS, is associated with beneficial changes in substrate metabolism. Cardiovasc Res 51: 275-282, 2001.
16. Teusink B, Voshol PJ, Dahlmans VE, Rensen PC, Pijl H, Romijn JA, and Havekes LM. Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes 52: 614-620, 2003.
17. Van Bennekum AM, Kako Y, Weinstock PH, Harrison EH, Deckelbaum RJ, Goldberg IJ, and Blaner WS. Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester. J Lipid Res 40: 565-574, 1999.
18. Van der Vusse G, van Bilsen M, and Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res 45: 279-293, 2000.
19. Yagyu H, Chen G, Yokoyama M, Hirata K, Augustus A, Kako Y, Seo T, Hu Y, Lutz EP, Merkel M, Bensadoun A, Homma S, and Goldberg IJ. Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy. J Clin Invest 111: 419-426, 2003.
20. Yokoyama M, Yagyu H, Hu Y, Seo T, Hirata K, Homma S, and Goldberg LJ. Apolipoprotein B production reduces lipotoxic cardiomyopathy: Studies in heart specific lipoprotein lipase transgenic mouse. J Biol Chem 279: 4204-4211, 2003.